Why data registries matter in cancer research
When people think about medical research, they often picture clinical trials testing new drugs or breakthrough discoveries in the laboratory.
But behind many of these advances is something less visible – data.
Data registries are a vital part of research. They systematically collect information about patients, treatments and outcomes over time, creating a real-world picture of how cancer is diagnosed, treated and managed.
While they may not attract the same attention as new therapies, registries play a critical role in improving care.
Building a clearer picture of cancer care
Clinical trials are designed to answer specific research questions under controlled conditions, helping to establish whether a treatment is safe and effective.
Real world data registries, by contrast, collect information from everyday clinical practice across large and diverse patient populations. This real-world data helps reveal patterns, outcomes, trends and gaps in care that might otherwise go unnoticed.
Importantly, registries can also be used within clinical research, including clinical trials. When they track outcomes that matter most to patients – such as being at home rather than in hospital, feeling well and not requiring ongoing pain relief or treatment, and ultimately survival – registries can help evaluate how changes in healthcare and treatment approaches improve future care. In this way, they allow us to test what works in the real world, not just in controlled settings.
Together, clinical trials and registries provide a more complete picture, combining tightly controlled evidence with insights from routine care across the broader community.
Turning everyday data into better care
At Icon Cancer Foundation, we are supporting new registry-based projects designed to strengthen how data is captured and used across the Icon Cancer Centre network in Australia.
One upcoming pilot study will explore how artificial intelligence (AI) can be used to improve the way clinical data is recorded and structured. By using AI transcription to capture information already collected during patient consultations, the project aims to create a research-ready dataset while reducing the time and cost associated with traditional data collection.
“One of the biggest challenges in clinical research is the time and cost involved in collecting high-quality data. This project is about finding a smarter way to use the information we’re already capturing in everyday patient care,” Dr Craig Gedye said.
“If we can streamline that process using AI, we can make research more efficient, more scalable, and more closely embedded in routine practice, ultimately helping us learn faster and improve care for our patients.”
Each patient interaction can add to a growing body of knowledge, helping clinicians spot patterns, refine treatments and continue improving care over time.
Strengthening complex areas of care
Data registries are particularly important in highly specialised and rapidly evolving areas of treatment.
Icon Cancer Foundation is also supporting the development of a prospective cellular therapy database, which will bring together detailed information on patients undergoing treatments such as stem cell transplants and CAR-T therapy.
Once established, this database will support real-world research, enable benchmarking across the program, and help clinicians track outcomes more accurately over time.
It’s also expected to help identify barriers in referral pathways and treatment timelines, providing opportunities to improve access and coordination of care for patients requiring these complex therapies.
“Cellular therapies are complex and rapidly evolving, and having access to high-quality, real-world data is essential to improving outcomes,” Dr Karthik Nath said.
“By building a comprehensive database across our network, we can better understand how these treatments are being delivered, track patient outcomes more accurately, and identify opportunities to improve care.
“This kind of data-driven approach will help ensure we are continuously learning and refining how we support patients undergoing these intensive therapies.”
A foundation for future progress
The value of a registry lies in what it enables.
These projects will support quality improvement, generate new research questions, and provide the evidence needed to refine treatment approaches. In many cases, they form the foundation for future clinical trials and larger-scale studies.
Unlike individual trials, registries are ongoing. Their impact grows over time, as more data is collected and insights deepen.z
Why this work matters
Maintaining high-quality data registries requires investment in systems, people and infrastructure.
At Icon Cancer Foundation, we recognise that advancing cancer care depends not only on breakthrough discoveries, but on the ability to learn from every patient experience.
By supporting data registries, we are helping to build the evidence base that improves care today and shapes the treatments of tomorrow.
Because progress in cancer care isn’t always about a single breakthrough. Often, it’s about what we learn through patients, over time.
